2-Chlorodeoxyadenosine (cladribine) induces apoptosis in human monocyte-derived dendritic cells

The response of human dendritic cells to co-ligation of pattern-recognition receptors

(2012) Tanja Dzopalic et al.   IMMUNOLOGIC RESEARCH

Effects of 2-Chlorodeoxyadenosine (Cladribine) on Primary Rat Microglia

(2012) Vikramjeet Singh et al.   Journal of Neuroimmune Pharmacology

The p53 network: cellular and systemic DNA damage responses in aging and cancer

(2012) H. Christian Reinhardt et al.   TRENDS IN GENETICS

Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse

(2011) Ana Longhini et al.   Journal of Neuroinflammation

Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis

(2011) Gavin Giovannoni et al.   LANCET NEUROLOGY

Immunomodulatory Effects of IFN-β and Lovastatin on Immunophenotype of Monocyte-Derived Dendritic Cells in Multiple Sclerosis

(2010) Halina Bartosik-Psujek et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Apoptogenic factors released from mitochondria

(2010) David L. Vaux   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Human CD141+(BDCA-3)+dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens

(2010) Sarah L. Jongbloed et al.   JOURNAL OF EXPERIMENTAL MEDICINE

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis

(2010) Gavin Giovannoni et al.   NEW ENGLAND JOURNAL OF MEDICINE

Interferon   induces mature dendritic cell apoptosis through caspase-11/caspase-3 activation

(2009) J.-H. Yen et al.   BLOOD

Pathophysiology of multiple sclerosis

(2009) Thomas Korn   JOURNAL OF NEUROLOGY

Decrease in the Numbers of Dendritic Cells and CD4+ T Cells in Cerebral Perivascular Spaces Due to Natalizumab

(2008) Maria del Pilar Martin   ARCHIVES OF NEUROLOGY